MP

Mehul Patel

Mehul Patel, Executive Director, CNS TA Lead, Global Medical Affairs



Professional Overview



Mehul Patel is an accomplished pharmaceutical executive with extensive expertise in global medical affairs, neuroscience therapeutic area leadership, and strategic program development. As the Executive Director, CNS TA Lead for Global Medical Affairs at Otsuka Pharmaceutical Companies (U.S.), he drives the strategic direction and operational excellence of the company's central nervous system (CNS) portfolio.

Experience Summary



Current Role



In his current role, Mehul is responsible for leading the CNS therapeutic area within Otsuka's Global Medical Affairs team. He oversees the strategic planning, resource allocation, and cross-functional collaboration to ensure the successful development and commercialization of Otsuka's CNS products. Mehul's strong background in medical affairs and therapeutic area leadership allows him to effectively bridge the gap between clinical research, regulatory affairs, and commercial operations.

Career Progression



Mehul's career in the pharmaceutical industry spans over 15 years, with a focus on neuroscience and medical affairs. Prior to his current role, he held positions of increasing responsibility at Otsuka, AbbVie (formerly Allergan/Forest), Biogen Idec, and PDL. His diverse experience includes clinical program leadership, global medical affairs strategy, and U.S. neuroscience therapeutic area management. Throughout his career, Mehul has consistently demonstrated his ability to drive innovative initiatives, foster cross-functional collaboration, and deliver impactful results.

Academic Background



Mehul holds a Ph.D. in Neuroscience from a renowned university, where he specialized in the study of central nervous system disorders and their underlying mechanisms. His strong academic background, combined with his industry experience, enables him to bridge the gap between scientific research and practical applications in the pharmaceutical field.

Areas of Expertise



  • Therapeutic area leadership in central nervous system (CNS) disorders

  • Global medical affairs strategy and execution

  • Cross-functional collaboration and stakeholder management

  • Clinical program development and lifecycle management

  • Regulatory affairs and compliance

  • Scientific communication and medical education


Professional Impact



Mehul has been instrumental in driving the success of several key CNS programs during his tenure at Otsuka and AbbVie. His contributions have led to the successful launch and commercialization of multiple products, positively impacting patient outcomes and advancing the company's position in the neuroscience market. Recognized for his strategic vision and operational excellence, Mehul has been a trusted advisor to senior leadership and has successfully navigated complex regulatory and commercial challenges.

Conclusion



With his extensive experience, robust scientific expertise, and proven track record of success, Mehul Patel is a valuable asset to Otsuka Pharmaceutical Companies. As the Executive Director, CNS TA Lead for Global Medical Affairs, he is poised to continue driving innovation, fostering collaborative partnerships, and delivering meaningful impact within the pharmaceutical industry.